Variants of toll-like receptor 4 predict cardiac recovery in patients with dilated cardiomyopathy

Journal of Biological Chemistry

Volumn 287, Issue 32, 2012, Pages 27236-27243

  Riad, Alexander ^a   Meyer Zu Schwabedissen, Henriette ^a   Weitmann, Kerstin ^a   Herda, Lars R ^a   Dörr, Marcus ^a   Empen, Klaus ^a   Kieback, Arne ^a   Hummel, Astrid ^a   Reinthaler, Marcus ^a   Grube, Marcus ^a   Klingel, Karin ^b   Nauck, Matthias ^a   Kandolf, Reinhard ^b   Hoffmann, Wolfgang ^a   Kroemer, Heyo K ^a   Felix, Stephan B ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD LEVELS; CARDIAC RECOVERY; CLINICAL COURSE; CORONARY ANGIOGRAPHY; DILATED CARDIOMYOPATHY; FOLLOW UP; HEART FAILURE; IMMUNE PROTEIN; LEFT VENTRICULAR; LEFT VENTRICULAR EJECTION FRACTION; MEDICAL TREATMENT; NATRIURETIC PEPTIDES; RISK FACTORS; TOLL-LIKE RECEPTOR 4; TREATMENT CONDITIONS; WILD TYPES;

CARDIOLOGY; ECHOCARDIOGRAPHY; GENES; PEPTIDES; TELEMEDICINE;

PATIENT TREATMENT;

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; TLR4 GENE; TREATMENT RESPONSE;

CARDIOMYOPATHY, DILATED; HUMANS; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 4;

EID: 84864546552     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.369728     Document Type: Article

References (34)

1. Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O'Connell, J., Olsen, E., Thiene, G., Goodwin, J., Gyarfas, I., Martin, I., and Nordet, P. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93, 841-842 (Pubitemid 26074816)
2. Sheppard, R., Bedi, M., Kubota, T., Semigran, M. J., Dec, W., Holubkov, R., Feldman, A. M., Rosenblum, W. D., McTiernan, C. F., and McNamara, D. M. (2005) Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy. J. Am. Coll. Cardiol. 46, 1036-1042 (Pubitemid 41316512)
3. Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., and Young, J. B. (2006) Contemporary definitions and classification of the cardiomyopathies. An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807-1816 (Pubitemid 43958474)
4. McNamara, D. M., Starling, R. C., Cooper, L. T., Boehmer, J. P., Mather, P. J., Janosko, K. M., Gorcsan, J., 3rd, Kip, K. E., Dec, G. W., IMAC Investigators (2011) Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J. Am. Coll. Cardiol. 58, 1112-1118
5. Feldman, A. M., and McNamara, D. (2000) Myocarditis. N. Engl. J. Med. 343, 1388-1398
6. Herda, L. R., Felix, S. B., and Staudt, A. (2009) Immunoadsorption in patients with dilated cardiomyopathy. Atheroscler. Suppl. 10, 126-128
7. Cooper, L. T., Jr. (2009) Myocarditis. N. Engl. J. Med. 360, 1526-1538
8. Kindermann, I., Kindermann, M., Kandolf, R., Klingel, K., Bültmann, B., Müller, T., Lindinger, A., and Böhm, M. (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118, 639-648
9. O'Neill, L. A., and Bowie, A. G. (2007) The family of five. TIR-domain-containing adaptors in Toll-like receptor signaling. Nat Rev Immunol. 7, 353-364 (Pubitemid 46674493)
10. Mann, D. L. (2011) The emerging role of innate immunity in the heart and vascular system. For whom the cell tolls. Circ. Res. 108, 1133-1145
11. Riad, A., Bien, S., Gratz, M., Escher, F., Westermann, D., Heimesaat, M. M., Bereswill, S., Krieg, T., Felix, S. B., Schultheiss, H. P., Kroemer, H. K., and Tschöpe, C. (2008) Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur. J. Heart Fail. 10, 233-243
12. Riad, A., Jäger, S., Sobirey, M., Escher, F., Yaulema-Riss, A., Westermann, D., Karatas, A., Heimesaat, M. M., Bereswill, S., Dragun, D., Pauschinger, M., Schultheiss, H. P., and Tschöpe, C. (2008) Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 180, 6954-6961
13. Kim, S. C., Ghanem, A., Stapel, H., Tiemann, K., Knuefermann, P., Hoeft, A., Meyer, R., Grohé, C., Knowlton, A. A., and Baumgarten, G. (2007) Toll-like receptor 4 deficiency. Smaller infarcts, but no gain in function. BMC Physiol. 7, 5
14. Oyama, J., Blais, C., Jr., Liu, X., Pu, M., Kobzik, L., Kelly, R. A., and Bourcier, T. (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109, 784-789 (Pubitemid 38222900)
15. Stapel, H., Kim, S. C., Osterkamp, S., Knuefermann, P., Hoeft, A., Meyer, R., Grohé, C., and Baumgarten G. (2006) Toll-like receptor 4 modulates myocardial ischemia-reperfusion injury. Role of matrix metalloproteinases. Eur. J. Heart Fail. 8, 665-672 (Pubitemid 44635319)
16. Shimamoto, A., Chong, A. J., Yada, M., Shomura, S., Takayama, H., Fleisig, A. J., Agnew, M. L., Hampton, C. R., Rothnie, C. L., Spring, D. J., Pohlman, T. H., Shimpo, H., and Verrier, E D. (2006) Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114, Suppl. 1, I270-I274 (Pubitemid 44297162)
17. Methe, H., Kim, J. O., Kofler, S., Weis, M., Nabauer, M., and Koglin J. (2005) Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 111, 2654-2661 (Pubitemid 40740866)
18. Boekholdt, S. M., Agema, W. R., Peters, R. J., Zwinderman, A. H., van der Wall, E. E., Reitsma, P. H., Kastelein, J. J., Jukema, J. W., and REgression GRowth Evaluation Statin Study Group (2003) Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107, 2416-2421 (Pubitemid 36605222)
19. Herda, L. R., Trimpert, C., Nauke, U., Landsberger, M., Hummel, A., Beug, D., Kieback, A., Dörr, M., Empen, K., Knebel, F., Ewert, R., Angelow, A., Hoffmann, W., Felix, S. B., and Staudt, A. (2010) Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy. Am. Heart J. 159, 809-816
20. Staudt, A., Schäper, F., Stangl, V., Plagemann, A., Böhm, M., Merkel, K., Wallukat, G., Wernecke, K. D., Stangl, K., Baumann, G., and Felix, S. B. (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103, 2681-2686 (Pubitemid 32538782)
21. Cheitlin, M. D., Alpert, J. S., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davidson, T. W., Davis, J. L., Douglas, P. S., and Gillam, L D. (1997) ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Circulation 95, 1686-1744 (Pubitemid 27142849)
22. Aretz, H. T., Billingham, M. E., Edwards, W. D., Factor, S. M., Fallon, J. T., Fenoglio, J. J., Jr., Olsen, E. G., and Schoen, F. J. (1987) Myocarditis. A histopathological definition and classification. Am. J. Cardiovasc. Pathol. 1, 3-14
23. Yilmaz, A., Kindermann, I., Kindermann, M., Mahfoud, F., Ukena, C., Athanasiadis, A., Hill, S., Mahrholdt, H., Voehringer, M., Schieber, M., Klingel, K., Kandolf, R., Böhm, M., and Sechtem U. (2010) Comparative evaluation of left and right ventricular endomyocardial biopsy. Differences in complication rate and diagnostic performance. Circulation 122, 900-909
24. Staudt, A., Staudt, Y., Hummel, A., Empen, K., Dörr, M., Trimpert, C., Birkenmeier, K., Kühl, U., Noutsias, M., Russ, D., and Felix, S. B. (2006) Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther. Apher. Dial. 10, 42-48
25. Lorenz, E., Frees, K. L., and Schwartz, D. A. (2001) Determination of the TLR4 genotype using allele-specific PCR. BioTechniques 31, 22-24 (Pubitemid 32645902)
26. Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., and Schwartz, D. A. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185-192 (Pubitemid 34764822)
27. Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., and Schwartz, D. A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187-191 (Pubitemid 30394990)
28. Erridge, C. (2010) Endogenous ligands of TLR2 and TLR4. Agonists or assistants? J. Leukocyte Biol. 87, 989-999
29. Garantziotis, S., Hollingsworth, J. W., Zaas, A. K., and Schwartz, D. A. (2008) The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu. Rev. Med. 59, 343-359 (Pubitemid 351287942)
30. Erridge, C., Stewart, J., and Poxton, I. R. (2003) Monocytes heterozygous for the Asp-299 → Gly and Thr-399 → Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signaling. J. Exp. Med. 197, 1787-1791 (Pubitemid 36745353)
31. Kawai, T., and Akira, S. (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann. N.Y. Acad. Sci. 1143, 1-20
32. Riad, A., Westermann, D., Zietsch, C., Savvatis, K., Becher, P. M., Bereswill, S., Heimesaat, M. M., Lettau, O., Lassner, D., Dörner, A., Poller, W., Busch, M., Felix, S. B., Schultheiss, H. P., and Tschöpe, C. (2011) TRIF is a critical survival factor in viral cardiomyopathy. J. Immunol. 186, 2561-2570
33. De Gennaro, L., Brunetti, N. D., Cuculo, A., Pellegrino, P. L., and Di Biase, M. (2008) Systemic inflammation in nonischemic dilated cardiomyopathy. Heart Vessels 23, 445-450
34. Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG) (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. J. Heart Fail. 10, 933-989